Role of DEA and FDA in Use of CBD and THC

Paul D. Werner, Esq.

Member, Buttaci, Leardi & Werner Law Firm, Princeton, NJ

This workshop will address the changing landscape relative to the use of cannabis-derived products, such as CBD oil and other CBD products. Federal statutes, such as the Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), the Federal Food, Drug, and Cosmetic Act (the “FD&C”), and FDA and DEA guidelines relative to the classification of cannabis-derived products intertwine to create a complex regulatory framework within which health care providers must operate. Understanding the various regulatory schemes in place and how cannabis-derived products can be used and marketed is fundamental to compliance with federal law and relevant agency guidelines. This workshop will identify the relevant regulatory guideposts and provide direction as it relates to compliance with and understanding of this changing landscape.